(EMAILWIRE.COM, June 09, 2023 ) The “Carrier Screening Market” was valued USD 2 Bn in 2022 and is expected to grow at a CAGR of 14.6 percent over the forecast period to reach USD 5.19 Bn by 2029.

Carrier Screening Market Scope and Research Methodology

Major service provider in the Carrier Screening Market are listed by region, total market revenue, financial status, advancements adopted by the market players and mergers & acquisitions. Primary and secondary research was conducted to collect data from the Carrier Screening Market.

Request For Free Sample Report: https://www.maximizemarketresearch.com/request-sample/186174

Carrier Screening Market Dynamics

Increasing genetic illness and disorders is expected to boost the Carrier Screening market growth over the forecast period. This test is cost effective, provides accurate result compared to traditional screening, which is significantly contributing for the market growth. Stringent regulations about the screening is expected to hinder the Carrier Screening Market growth.

Carrier Screening Market Regional Insight

North America region is expected to boost the Carrier Screening Market growth over the forecast period. The region is expected to grow with a growth rate of 11.9 percent by 2029. Federal government is promoting the market in the region, which is expected to boost the market growth.

Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/186174

Carrier Screening Market Segmentation

By Type:
Expanded Carrier Screening
Customized Panel Testing
Predesigned Panel Testing
Targeted Disease Carrier Screening

By Medical Condition:
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Other Conditions

By Technology:
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others

By End User:
Hospitals and clinics
Reference Laboratories
Physician Offices
Others

Carrier Screening Market Key Players Include

Fulgent Genetics Inc.
Illumina Inc.
Diasorin S.p.A.
Natera Inc.
Thermo Fisher Scientific Inc.
Eurofins Scientific
Myriad Genetics Inc.
Opko Health Inc
Quest Diagnostics Inc.
InVitae Corporation
Sena4

Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/186174

Maximize Market Research is leading Information Biotechnology research firm, has also published the following reports:

Lung Cancer Screening Market : The market size is expected to reach USD 4.13 Bn by 2029 at a CAGR of 8.32 percent during the forecast period.

Drug and Alcohol Screening Market : The market size is expected to reach USD 19.21 Bn by 2029 at a CAGR of 17.2 percent over the forecast period.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.